昔日千亿市值独角兽,被收购

生物科技馆
22 Feb

明星Biotech蓝鸟生物,昔日千亿市值独角兽,最终还是选择了“卖身”。当地时间2月21日,蓝鸟生物宣布,将被全球投资公司凯雷和由SK Capital管理的基金收购。Mirati Therapeutics 和益普生(Ipsen)的前首席执行官David Meek预计将在交易完成后成为蓝鸟的首席执行官。凯雷和SK Capital 将向蓝鸟生物提供资金,以促进蓝鸟生物治疗镰状细胞病、β地中海贫血和脑...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10